| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/28/2023 | 32.53% | Stifel | → $11 | Initiates Coverage On | → Hold |
| 08/04/2023 | — | Raymond James | Downgrades | Strong Buy → Outperform | |
| 05/11/2023 | 116.87% | TD Cowen | $14 → $18 | Maintains | Outperform |
| 05/11/2023 | 89.76% | Alliance Global Partners | $13.15 → $15.75 | Maintains | Buy |
| 03/21/2023 | 20.48% | Jefferies | $5.5 → $10 | Downgrades | Buy → Equal-Weight |
| 11/04/2022 | — | Raymond James | Upgrades | Outperform → Strong Buy | |
| 03/07/2022 | 68.67% | Cowen & Co. | $28 → $14 | Maintains | Outperform |
| 02/22/2022 | 177.11% | Raymond James | $28 → $23 | Downgrades | Strong Buy → Outperform |
| 09/15/2020 | — | Jefferies | Initiates Coverage On | → Buy | |
| 09/10/2020 | 165.06% | Lake Street | → $22 | Initiates Coverage On | → Buy |
| 04/01/2020 | 80.72% | Cowen & Co. | → $15 | Initiates Coverage On | → Outperform |
What is the target price for Profound Medical (PROF)?
The latest price target for Profound Medical (NASDAQ: PROF) was reported by Stifel on November 28, 2023. The analyst firm set a price target for $11.00 expecting PROF to rise to within 12 months (a possible 32.53% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Profound Medical (PROF)?
The latest analyst rating for Profound Medical (NASDAQ: PROF) was provided by Stifel, and Profound Medical initiated their hold rating.
When is the next analyst rating going to be posted or updated for Profound Medical (PROF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Profound Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Profound Medical was filed on November 28, 2023 so you should expect the next rating to be made available sometime around November 28, 2024.
Is the Analyst Rating Profound Medical (PROF) correct?
While ratings are subjective and will change, the latest Profound Medical (PROF) rating was a initiated with a price target of $0.00 to $11.00. The current price Profound Medical (PROF) is trading at is $8.30, which is within the analyst's predicted range.
